Inflammation and stroke: Therapeutic effects of adenoviral expression of secretory leukocyte protease inhibitor

被引：6

作者：

Feuerstein, G ^{[1
]}

机构：

[1] Wyeth Res, Translat Med, Collegeville, PA 19426 USA

来源：

FRONTIERS IN BIOSCIENCE-LANDMARK | 2006年 / 11卷

关键词：

nervous system; neuron; brain; stroke; inflammation; protease inhibitors; and leukocytes; SLPI; review;

D O I：

10.2741/1920

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Inflammation is a fundamental reaction of the organism aimed to protect, defend and amend diverse forms of injuries. Stroke, an ischemic condition of the brain, provokes acute and chronic inflammatory reactions composed of brain cells as well as circulating immune inflammatory cells. In response to ischemia, brain cells transcribe and express inflammatory proteins that orchestrate numerous biochemical pathways, some of which of potential detrimental effects. This review paper is aimed to delineate strategies that may enable the discovery of novel therapeutic targets for the discovery of drugs for stroke. Soluble Leukocyte Protease Inhibitor ( SLPI) serves as a prime example for this strategy.

引用

页码：1750 / 1757

页数：8

共 59 条

[11] POLYMORPHONUCLEAR LEUKOCYTES OCCLUDE CAPILLARIES FOLLOWING MIDDLE CEREBRAL-ARTERY OCCLUSION AND REPERFUSION IN BABOONS [J].

DELZOPPO, GJ ;

SCHMIDSCHONBEIN, GW ;

MORI, E ;

COPELAND, BR ;

CHANG, CM .

STROKE, 1991, 22 (10) :1276-1283

[12] Osteopontin and its integrin receptor αVβ3 are upregulated during formation of the glial scar after focal stroke [J].

Ellison, JA ;

Velier, JJ ;

Spera, P ;

Jonak, ZL ;

Wang, XK ;

Barone, FC ;

Feuerstein, GZ .

STROKE, 1998, 29 (08) :1698-1706

[13] The role of leukocytes following cerebral ischemia: Pathogenic variable or bystander reaction to emerging infarct? [J].

Emerich, DF ;

Dean, RL ;

Bartus, RT .

EXPERIMENTAL NEUROLOGY, 2002, 173 (01) :168-181

[14] Recommendations for standards regarding preclinical neuroprotective and restorative drug development [J].

Feinklestein, SP ;

Fisher, M ;

Furland, AJ ;

Goldstein, LB ;

Gorelick, PB ;

Kaste, M ;

Lees, KR ;

Traystman, RJ ;

Albers, GW ;

Anwer, UE ;

Ashwood, T ;

Barone, FC ;

Basta, SL ;

Bogousslavsky, J ;

Buchan, AM ;

Cady, WJ ;

Chan, PH ;

Clemens, JA ;

Cox, BF ;

Craddock, RE ;

Cramer, SC ;

del Zoppo, GJ ;

Dielrich, WD ;

Elliott, P ;

Faden, AI ;

Feuerstein, GZ ;

Ginsberg, MD ;

Gold, M ;

Greene, WL ;

Hall, ED ;

Hsu, CY ;

Hunter, AJ ;

Lai, M ;

Lesko, LM ;

Levy, DE ;

Li, FH ;

Locke, KW ;

Lodge, D ;

Lowe, D ;

Marcoux, FW ;

McCulloch, J ;

McDermott, J ;

Meibach, R ;

Messersmith, EK ;

Moseley, M ;

Moskowitz, MA ;

Mueller, AL ;

Munro, F ;

Nudo, RJ ;

Oeda, J .

STROKE, 1999, 30 (12) :2752-2758

[15]

FEUERSTEIN GZ, 2002, HANDB EXP PHARM, V155, P281

[16] INHIBITION OF MAST-CELL CHYMASE BY EGLIN-C AND ANTILEUKOPROTEASE (HUSI-I) - INDICATIONS FOR POTENTIAL BIOLOGICAL FUNCTIONS OF THESE INHIBITORS [J].

FINK, E ;

NETTELBECK, R ;

FRITZ, H .

BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1986, 367 (07) :567-571

[17] Recommendations for advancing development of acute stroke therapies - Stroke Therapy Academic Industry Roundtable 3 [J].

Fisher, M .

STROKE, 2003, 34 (06) :1539-1546

[18]

FRITZ H, 1988, BIOL CHEM H-S, V369, P79

[19]

FURLAN A, 2004, STROKE PATHOPHYSIOLO, P943

[20] Localization of macrophage inflammatory protein:: Macrophage inflammatory PROTEIN-1 expression in rat brain after peripheral administration of lipopolysaccharide and focal cerebral ischemia [J].

Gourmala, NG ;

Limonta, S ;

Bochelen, D ;

Sauter, A ;

Boddeke, HWGM .

NEUROSCIENCE, 1999, 88 (04) :1255-1266

← 1 2 3 4 5 6 →